Conclusion: The method is linear, sensitive, specific and can be used for the enantioselective assay of CLP enantiomers in pharmaceutical formulations.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background and Aims: An HPLC method with photodiode array detector on a chiral column was proposed for enantioselective determination of chlorpheniramine (CLP) enantiomers in dosage forms.
📊
Key Findings & Data:Methods: The enantioselective determination was achieved on amylose tris(3,5-dimethylphenylcarbamate) column, using n-hexane-(propan-2-ol)-diethylamine (97.5:2.5:0.025, v/v/v) mobile phase.
💡
Conclusion & Impact:Conclusion: The method is linear, sensitive, specific and can be used for the enantioselective assay of CLP enantiomers in pharmaceutical formulations.
Background and Aims: An HPLC method with photodiode array detector on a chiral column was proposed for enantioselective determination of chlorpheniramine (CLP) enantiomers in dosage forms. Methods: The enantioselective determination was achieved on amylose tris(3,5-dimethylphenylcarbamate) column, using n-hexane-(propan-2-ol)-diethylamine (97.5:2.5:0.025, v/v/v) mobile phase. The peaks were detected at 258 nm. Diphenhydramine was used as an internal standard (IS). A new sample preparation procedure was developed to avoid the interference of the other ingredients present in the formulations. Results: Limit of quantification of the proposed method was 0.88 and 1.31 μg/mL for S-(+)-CLP and R-(-)-CLP, respectively. Conclusion: The method is linear, sensitive, specific and can be used for the enantioselective assay of CLP enantiomers in pharmaceutical formulations.
ERENSOY, G., TAŞKIN, D., ARTUÇ, G. Ö., ÖZDEMİR, E., ÖZKIRIMLI, S. (2020). Determination of chlorpheniramine enantiomers in pharmaceutical formulations by HPLC on chiral column with PDA detection. İstanbul Journal of Pharmacy, Cilt: 50 - Sayı: 2, 149–152. https://ajindex.com/articles/92726
Calcaterra, A., & D’Acquarica I. (2018). The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds Journal of Pharmaceutical and Biomedical Analysis, 147, 323–340.
Chen, Q., Jeong, S., Hwang, G., Kim, K., & Kang, J. (2008). Enantioselective determination of chlorpheniramine in various formulations by HPLC using carboxymethyl-β-cyclodextrin as a chiral additive. Archives of pharmacal research, 31, 523-529.
Fried, K. M., Young, A. E., Yasuda, U. S., & Wainer, I. W. (2001). The enantioselective determination of chlorpheniramine and its major metabolites in human plasma using chiral chromatography on a β-cyclodextrin chiral stationary phase and mass spectrometric detection. Journal of Pharmaceutical and Biomedical Analysis, 27, 479–488.
Granberg, R. A., & Rasmuson, A. C. (1999). Solubility of paracetamol in pure solvents. Journal of Chemical & Engineering Data, 44, 1391– 1395. Hiep, B. T., Khanh, V., Hung, N. K., Thuillier, A., & Gimenez, F. (1998). Determination of enantiomers of chlorpheniramine and its main monodesmethyl metabolite in urine using achiral-chiral liquid chromatography. Journal of Chromatography B. 707, 235–240. International Conference on Harmonization. ICH. 2005. Validation of Analytical Procedures: Text and Methodology Q2 R1. Geneva: International Conference on Harmonization. Available from: https://www.gmp-compliance.org/guidemgr/files/Q2(R1).pdf
Tagawa, M., Kano, M., Okamura, N., Higuchi, M., Matsuda, M., Mizuki, Y., Yanai, K. (2002). Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: Correlation between cognitive impairment and plasma drug concentration. British Journal of Clinical Pharmacology, 53, 296–304.
Tanda, G., Kopajtic, T. A., & Katz, J. L. (2008). Cocaine-like neurochemical effects of antihistaminic medications. Journal of Neuro- Chemistry, 106, 147–157.